Assisted Reproduction Technology Treatment Outcomes in Female Carriers of 21-Hydroxylase Deficiency

Medical Journal

Apr 2

Written By Abby Hunt

Arcaz AC, Hernandez-Nieto C, Lee JA, Cacchione TA, Mukherjee T, Copperman AB. Assisted Reproduction Technology Treatment Outcomes in Female Carriers of 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2025 Apr 2:dgaf198. doi: 10.1210/clinem/dgaf198. Epub ahead of print. PMID: 40171917.

Abby Hunt

The number of autologous, vitrified mature oocytes needed to obtain three euploid blastocysts increases with age

Introducing Time-Lapse for Flexible Embryo Assessment in IVF: Implications for Grading Confidence and Workflow Efficiency

Fertility Centers of Illinois (Copy)

IVF Florida (Copy)

Ovation Fertility (Copy)

RMA of New York (Copy)

RSC Bay Area (Copy)

Shady Grove Fertility (Copy)

About News Careers Contact

Terms & Conditions Privacy Statement Public Notices

Copyright © 2025 US Fertility